REDRESSING THE BALANCE - THE ETHICS OF NOT ENTERING AN ELIGIBLE PATIENT ON A RANDOMIZED CLINICAL-TRIAL - POINT-OF-VIEW

A double standard exists whereby a treatment given outside a clinical trial is less stringently reviewed than a protocol treatment. We propose a remedy which would require the decision not to participate in an approved, available clinical trial to be subject to the same ethical requirements as trial entry.